Skip to content
J1833Senate2023-2024 SessionResolution

Declare Alport Syndrome Awareness Month

Official title

“Memorializing Governor Kathy Hochul to proclaim March 2024, as Alport Syndrome Awareness Month in the State of New York”

Sponsor Gustavo RiveraSD-33
Status
Adopted
Impact
2/10
Minimal
Outcome
Adopted

What's happening

The resolution urges Governor Hochul to declare March 2024 as Alport Syndrome Awareness Month in New York State.

Why it matters

  1. Raising awareness of Alport Syndrome can lead to earlier diagnoses. since the disease is rare and often misdiagnosed, increased public and medical professional recognition may help affected individuals access care and support more quickly.

  2. Highlighting the lack of FDA-approved treatments for Alport Syndrome underscores a need for research funding and innovation. , potentially encouraging advocacy for medical research and pharmaceutical investment in this neglected area.

  3. Encouraging genetic testing and education about Alport Syndrome. can help families understand inheritance patterns, manage health risks, and make informed decisions, especially since this disease can be passed to future generations.

  4. State-level recognition can reduce stigma and build community among those affected by rare diseases. , fostering support networks and drawing attention to the broader challenges faced by people with rare and under-recognized health conditions.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Declare Alport Syndrome Awareness Month

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

No co-sponsors yet.

History

  1. Adopted
  2. Reported to calendar for consideration
  3. Referred to finance

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

Senate Resolution No. 1833 BY: Senator RIVERA MEMORIALIZING Governor Kathy Hochul to proclaim March 2024, as Alport Syndrome Awareness Month in the State of New York WHEREAS, The State of New York takes great pride in recognizing serious genetic diseases by… Show all

Senate Resolution No. 1833 BY: Senator RIVERA MEMORIALIZING Governor Kathy Hochul to proclaim March 2024, as Alport Syndrome Awareness Month in the State of New York WHEREAS, The State of New York takes great pride in recognizing serious genetic diseases by proclaiming official months to increase awareness of such concerns, which affect thousands of New Yorkers; and WHEREAS, It is the sense of this Legislative Body to memorialize Governor Kathy Hochul to proclaim March 2024, as Alport Syndrome Month in the State of New York; and WHEREAS, Since 2014, this month-long campaign has aimed to spotlight this rare, genetic kidney disease during National Kidney Awareness Month; and WHEREAS, Alport Syndrome is a rare genetic disorder characterized by progressive kidney disease and abnormalities of the inner ear and the eye; and WHEREAS, The disease we now know as Alport Syndrome was first described in the British medical literature in the early years of the 20th Century; in 1927, Dr. Cecil Alport published a paper describing the association of kidney disease and deafness in affected individuals, and in 1961, the disorder was named after Dr. Alport; and WHEREAS, There are four genetic types: X-linked Alport syndrome (XLAS); autosomal recessive Alport syndrome (ARAS); autosomal dominant Alport syndrome (ADAS); and digenic Alport syndrome (a combination of Alport mutations); disease progression can vary based on genetic type; and WHEREAS, The hallmark of the disease is the presence of blood in the urine (hematuria) early in life, with progressive decline in kidney function (kidney insufficiency); there is currently no FDA-approved treatment to delay or stop renal function decline as a result of Alport syndrome; and WHEREAS, Alport Syndrome is often discussed with a related disorder known as thin basement membrane nephropathy (TBMN), in which the predominant pathologic abnormality is thinning of glomerular basement membranes; and WHEREAS, Alport Syndrome is estimated to affect less than 200,000 people in the general population in the United States making it a rare disease; while no exact prevalence data is available, increased access to genetic testing allows more patients to receive a confirmed diagnosis; and WHEREAS, It is imperative that there be greater awareness of this serious health condition, and more must be done to increase activity at local, State and National levels; now, therefore, be it RESOLVED, That this Legislative Body pause in its deliberations to memorialize Governor Kathy Hochul to proclaim March 2024, as Alport Syndrome Awareness Month in the State of New York, and to urge the citizens of this great Empire State to learn about the causes, symptoms, diagnoses and treatments for Alport Syndrome; and be it further RESOLVED, That a copy of this Resolution, suitably engrossed, be transmitted to The Honorable Kathy Hochul, Governor of the State of New York.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.